Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Sides

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Antimicrobial Chemotherapy|March 1, 1993
Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitisG D Sides
Antimicrobial Agents and Chemotherapy|September 1, 1989
New directions for macrolide antibiotics: structural modifications and in vitro activityH A Kirst, G D Sides
Antimicrobial Agents and Chemotherapy|September 1, 1989
New directions for macrolide antibiotics: pharmacokinetics and clinical efficacyH A Kirst, G D Sides
The Journal of Antimicrobial Chemotherapy|March 1, 1993
Safety profile of dirithromycinG D Sides, P M Conforti
The Journal of Antimicrobial Chemotherapy|March 1, 1993
Dirithromycin in the treatment of streptococcal pharyngitisM Derriennic, P M Conforti, G D Sides
The Journal of Antimicrobial Chemotherapy|June 1, 1999
Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitisM M Wasilewski, D Johns, G D Sides
The Journal of Antimicrobial Chemotherapy|August 10, 2000
Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infectionsM M Wasilewski, M G Wilson, G D Sides, et al.
Journal of the Reticuloendothelial Society|May 1, 1981
Transformation of energy charge and phosphofructokinase activity in alveolar macrophagesG D Sides, N M Mantich, L A Boxer, et al.
Clinical Therapeutics|November 1, 1996
Clinical efficacy of dirithromycin in patients with bacteremic pneumoniaJ M Hernández, G D Sides, P M Conforti, et al.
Clinical Therapeutics|January 1, 1988
A comprehensive review of the clinical pharmacology and pharmacokinetics of cefaclorG D Sides, T R Franson, K A DeSante, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Antimicrobial Chemotherapy|March 1, 1993
Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitisG D Sides
Antimicrobial Agents and Chemotherapy|September 1, 1989
New directions for macrolide antibiotics: structural modifications and in vitro activityH A Kirst, G D Sides
Antimicrobial Agents and Chemotherapy|September 1, 1989
New directions for macrolide antibiotics: pharmacokinetics and clinical efficacyH A Kirst, G D Sides
The Journal of Antimicrobial Chemotherapy|March 1, 1993
Safety profile of dirithromycinG D Sides, P M Conforti
The Journal of Antimicrobial Chemotherapy|March 1, 1993
Dirithromycin in the treatment of streptococcal pharyngitisM Derriennic, P M Conforti, G D Sides
The Journal of Antimicrobial Chemotherapy|June 1, 1999
Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitisM M Wasilewski, D Johns, G D Sides
The Journal of Antimicrobial Chemotherapy|August 10, 2000
Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infectionsM M Wasilewski, M G Wilson, G D Sides, et al.
Journal of the Reticuloendothelial Society|May 1, 1981
Transformation of energy charge and phosphofructokinase activity in alveolar macrophagesG D Sides, N M Mantich, L A Boxer, et al.
Clinical Therapeutics|November 1, 1996
Clinical efficacy of dirithromycin in patients with bacteremic pneumoniaJ M Hernández, G D Sides, P M Conforti, et al.
Clinical Therapeutics|January 1, 1988
A comprehensive review of the clinical pharmacology and pharmacokinetics of cefaclorG D Sides, T R Franson, K A DeSante, et al.
Pageof 2